Skip to main content

Adam Bress receives R01 Funding

Dec 18, 2017

We are pleased to announce Adam Bress has received his R01 Funding for Patient Level Prediction of Clinical Outcomes and Cost-Effectiveness in SPRINT.

The Optimize-SPRINT study is an ancillary study to the landmark SPRINT trial that compared intensive versus standard blood pressure-lowering treatment. Optimize-SPRINT will use predictive modeling and health economic methods to facilitate selection of optimal population groups and individual patients for intensive high blood pressure treatment. 

Congratulations, Dr. Bress!